loadpatents
Patent applications and USPTO patent grants for Baraldi; Pier Giovanni.The latest application filed is for "novel anti-cancer compounds".
Patent | Date |
---|---|
Anti-cancer compounds Grant 9,278,958 - Balzarini , et al. March 8, 2 | 2016-03-08 |
Novel Anti-cancer Compounds App 20150126559 - Balzarini; Jan ;   et al. | 2015-05-07 |
Biarylcarboxyarylamides as vanilloid-1 receptor modulators Grant 8,222,275 - Baraldi , et al. July 17, 2 | 2012-07-17 |
Allosteric Enhancers of th A1 Adenosine Receptor App 20120108636 - Baraldi; Pier Giovanni ;   et al. | 2012-05-03 |
Vanilloid TRPV1 receptor antagonists Grant 7,964,642 - Baraldi , et al. June 21, 2 | 2011-06-21 |
VR1 vanilloid receptor antagonists with a iononic substructure Grant 7,919,624 - Baraldi , et al. April 5, 2 | 2011-04-05 |
Allosteric Modulators of the A1 Adenosine Receptor App 20110053917 - Baraldi; Pier Giovanni ;   et al. | 2011-03-03 |
Allosteric modulators of the A.sub.1 adenosine receptor Grant 7,897,596 - Baraldi , et al. March 1, 2 | 2011-03-01 |
Allosteric modulators of the A.sub.1 adenosine receptor Grant 7,855,209 - Baraldi , et al. December 21, 2 | 2010-12-21 |
Adenosine A2B receptor antagonists Grant 7,767,685 - Baraldi , et al. August 3, 2 | 2010-08-03 |
O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists Grant 7,750,049 - Baraldi , et al. July 6, 2 | 2010-07-06 |
O-substituted-dibenzyl Urea-derivatives As Trpv1 Receptor Antagonists App 20100105740 - Baraldi; Pier Giovanni ;   et al. | 2010-04-29 |
Adenosine A.sub.2B receptor agonists Grant 7,691,825 - Baraldi , et al. April 6, 2 | 2010-04-06 |
Biarylcarboxyarylamides As Vanilloid-1 Receptor Modulators App 20100081687 - BARALDI; Pier Giovanni | 2010-04-01 |
Vr1 Vanilloid Receptor Antagonists With A Iononic Substructure App 20100035923 - Baraldi; Pier Giovanni ;   et al. | 2010-02-11 |
Allosteric Enhancers Of The A1 Adenosine Receptor App 20090281145 - Baraldi; Pier Giovanni ;   et al. | 2009-11-12 |
Novel Adenosine A3 Receptor Agonists App 20090233878 - Baraldi; Pier Giovanni ;   et al. | 2009-09-17 |
Sulfonamido compounds that antagonize the vanilloid TRPV1 receptor Grant 7,579,378 - Baraldi , et al. August 25, 2 | 2009-08-25 |
Enhancing Treatment Of Mdr Cancer With Adenosine A3 Antagonists App 20090203719 - Borea; Pier Andrea ;   et al. | 2009-08-13 |
Sulfonamido Compounds That Antagonise The Vanilloid Trpv1 Receptor App 20090118374 - Baraldi; Pier Giovanni ;   et al. | 2009-05-07 |
Adenosine A.sub.3 receptor agonists Grant 7,511,133 - Baraldi , et al. March 31, 2 | 2009-03-31 |
Adenosine A3 receptor modulators Grant 7,470,698 - Baraldi , et al. December 30, 2 | 2008-12-30 |
Pharmaceutically active compounds and methods of use Grant 7,449,490 - Moorman , et al. November 11, 2 | 2008-11-11 |
Adenosine A.sub.3 receptor modulators Grant 7,435,740 - Baraldi , et al. October 14, 2 | 2008-10-14 |
Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of .beta.-thalassaemia Grant 7,396,851 - Baraldi , et al. July 8, 2 | 2008-07-08 |
Allosteric Modulators Of The A1 Adenosine Receptor App 20080125438 - Baraldi; Pier Giovanni ;   et al. | 2008-05-29 |
Allosteric Modulators Of The A1 Adenosine Receptor App 20080119460 - Baraldi; Pier Giovanni ;   et al. | 2008-05-22 |
Vanilloid Trpv1 Receptor Antagonists App 20080085936 - BARALDI; Pier Giovanni ;   et al. | 2008-04-10 |
8-heteroaryl xanthine adenosine A.sub.2B receptor antagonists Grant 7,335,655 - Baraldi , et al. February 26, 2 | 2008-02-26 |
Adenosine A2b Receptor Antagonists App 20080045549 - Baraldi; Pier Giovanni ;   et al. | 2008-02-21 |
Adenosine A2b Receptor Agonists App 20070281902 - Baraldi; Pier Giovanni ;   et al. | 2007-12-06 |
Adenosine A3 Receptor Modulators App 20070249641 - Baraldi; Pier Giovanni ;   et al. | 2007-10-25 |
Adenosine A.sub.3 receptor modulators Grant 7,271,171 - Baraldi , et al. September 18, 2 | 2007-09-18 |
8-Heteroaryl xanthine adenosine A.sub.2B receptor antagonists Grant 7,205,403 - Baraldi , et al. April 17, 2 | 2007-04-17 |
Allosteric adenosine receptor modulators Grant 7,112,607 - Baraldi September 26, 2 | 2006-09-26 |
Enhancing treatment of cancer and HIF-1 mediated disorders with adenosine A3 receptor antagonists App 20060204502 - Borea; Pier Andrea ;   et al. | 2006-09-14 |
Pharmaceutically active compounds and methods of use Grant 7,101,905 - Moorman , et al. September 5, 2 | 2006-09-05 |
Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonists App 20060194756 - Borea; Pier Andrea ;   et al. | 2006-08-31 |
Tyrosyl derivatives and their use as P2X7 receptor modulators Grant 7,094,895 - Baraldi , et al. August 22, 2 | 2006-08-22 |
Pharmaceutically active compounds and methods of use App 20060183921 - Moorman; Allan R. ;   et al. | 2006-08-17 |
Novel adenosine A3 receptor modulators App 20060178385 - Baraldi; Pier Giovanni ;   et al. | 2006-08-10 |
8-Heteroaryl xanthine adenosine A2B receptor antagonists App 20060142309 - Baraldi; Pier Giovanni ;   et al. | 2006-06-29 |
Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use Grant 7,064,204 - Baraldi , et al. June 20, 2 | 2006-06-20 |
Adenosine A3 receptor modulators App 20060040959 - Baraldi; Pier Giovanni ;   et al. | 2006-02-23 |
Novel adenosine A3 receptor agonists App 20050250729 - Baraldi, Pier Giovanni ;   et al. | 2005-11-10 |
Adenosine A3 receptor modulators Grant 6,921,825 - Baraldi , et al. July 26, 2 | 2005-07-26 |
Enhancing treatment of MDR cancer with adenosine A3 antagonists App 20050119289 - Borea, Pier Andrea ;   et al. | 2005-06-02 |
Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia App 20040259799 - Baraldi, Pier Giovanni ;   et al. | 2004-12-23 |
Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents Grant 6,753,316 - Cozzi , et al. June 22, 2 | 2004-06-22 |
Allosteric adenosine receptor modulators Grant 6,727,258 - Baraldi April 27, 2 | 2004-04-27 |
Allosteric adenosine receptor modulators App 20040077630 - Baraldi, Pier Giovanni | 2004-04-22 |
Enhancing treatment of MDR cancer with adenosine A3 antagonists App 20040067932 - Borea, Pier Andrea ;   et al. | 2004-04-08 |
Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use App 20040039004 - Baraldi, Pier Giovanni ;   et al. | 2004-02-26 |
8-Heteroaryl xanthine adenosine A2B receptor antagonists App 20030207879 - Baraldi, Pier Giovanni ;   et al. | 2003-11-06 |
Tyrosyl derivatives and their use as P2X7 receptor modulators App 20030181452 - Baraldi, Pier Giovanni ;   et al. | 2003-09-25 |
Adenosine A3 receptor modulators App 20030144266 - Baraldi, Pier Giovanni ;   et al. | 2003-07-31 |
Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents Grant 6,596,845 - Cozzi , et al. July 22, 2 | 2003-07-22 |
Pharmaceutically active compounds and methods of use App 20030073733 - Moorman, Allan R. ;   et al. | 2003-04-17 |
Allosteric adenosine receptor modulators App 20020147231 - Baraldi, Pier Giovanni | 2002-10-10 |
Allosteric adenosine receptor modulators App 20020147185 - Baraldi, Pier Giovanni | 2002-10-10 |
Allosteric adenosine receptor modulators App 20020143004 - Baraldi, Pier Giovanni | 2002-10-03 |
Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents Grant 6,458,768 - Cozzi , et al. October 1, 2 | 2002-10-01 |
Allosteric adenosine receptor modulators App 20010047008 - Baraldi, Pier Giovanni | 2001-11-29 |
Allosteric adenosine receptor modulators Grant 6,323,214 - Baraldi November 27, 2 | 2001-11-27 |
N.sup.6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator Grant 6,048,865 - Baraldi April 11, 2 | 2000-04-11 |
1,2,4-triazolo[1,5-c] pyrimidine heterocyclic analogues having antagonistic activity on adenosine A.sub.2a receptor Grant 5,935,964 - Baraldi , et al. August 10, 1 | 1999-08-10 |
Distamycin A analogues as antitumour or antiviral agents Grant 5,753,629 - Beria , et al. May 19, 1 | 1998-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.